Ignite Creation Date:
2024-05-05 @ 4:55 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00346775
Status:
COMPLETED
Last Update Posted:
2018-01-16
First Post:
2006-06-28
Brief Title:
Validation Of Preference Module Of Experience With Allergic Rhinitis Nasal Sprays Questionnaire EARNS-Q
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
A Randomized Single-Blind Cross-Over Multicenter Study to Validate the Preference Module of the Experience With Allergic Rhinitis Nasal Sprays Questionnaire EARNS-Q Administered to Adult Subjects With Seasonal Allergic Rhinitis During a Three-week Cross-over Study
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Protocol section needs to be updated using the following text The main goal of the study was to validate the Preference Module of the EARNS-Q and to test the reliability using Treatment Satisfaction Questionnaire for Medicines TSQM a validated questionnaire for determining satisfaction among different treatment The EARNS-Q is divided into 2 modules an Experience Module and a Preference Module The Experience Module includes 28 items fourteen attribute rating items followed by fourteen importance weighing questions The Preference Module includes the same items along with preference questions related to each item as well as a global preference question
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None